Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005017248 | SCV005638459 | uncertain significance | Familial juvenile hyperuricemic nephropathy type 1 | 2024-05-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004739997 | SCV005356026 | uncertain significance | UMOD-related disorder | 2024-08-13 | no assertion criteria provided | clinical testing | The UMOD c.1469T>C variant is predicted to result in the amino acid substitution p.Met490Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |